Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY, Friedman AJ.
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1803-15. doi: 10.1016/j.addr.2013.07.011. Epub 2013 Jul 24.
Biomaterial-based delivery platforms for transdermal immunotherapy.
Dahri M, Beheshtizadeh N, Seyedpour N, Nakhostin-Ansari A, Aghajani F, Seyedpour S, Masjedi M, Farjadian F, Maleki R, Adibkia K.
Biomed Pharmacother. 2023 Sep;165:115048. doi: 10.1016/j.biopha.2023.115048. Epub 2023 Jun 28.
The carrier state: Neisseria gonorrhoeae.
Barlow D.
J Antimicrob Chemother. 1986 Jul;18 Suppl A:73-9. doi: 10.1093/jac/18.supplement_a.73.
The frequency of Neisseria gonorrhoeae endocervical infection among female carrier and changing trends of antimicrobial susceptibility patterns in Kashan, Iran.
Afrasiabi S, Moniri R, Samimi M, Mousavi SG.
Iran J Microbiol. 2014 Jun;6(3):194-7.
Th1-polarized MtrE-based gonococcal vaccines display prophylactic and therapeutic efficacy.
Song S, Wang S, Jiang X, Yang F, Gao S, Lin X, Cheng H, van der Veen S.
Emerg Microbes Infect. 2023 Dec;12(2):2249124. doi: 10.1080/22221751.2023.2249124.
Gonococcal disease.
Lightfoot RW Jr, Gotschlich EC.
Am J Med. 1974 Mar;56(3):327-56. doi: 10.1016/0002-9343(74)90616-0.
Neisseria gonorrhoeae Blocks Epithelial Exfoliation by Nitric-Oxide-Mediated Metabolic Cross Talk to Promote Colonization in Mice.
Muenzner P, Hauck CR.
Cell Host Microbe. 2020 May 13;27(5):793-808.e5. doi: 10.1016/j.chom.2020.03.010. Epub 2020 Apr 13.
Non-pathogenic Neisseria: members of an abundant, multi-habitat, diverse genus.
Liu G, Tang CM, Exley RM.
Microbiology (Reading). 2015 Jul;161(7):1297-1312. doi: 10.1099/mic.0.000086. Epub 2015 Mar 26.
Resistant penicillin-binding proteins.
Hakenbeck R, Coyette J.
Cell Mol Life Sci. 1998 Apr;54(4):332-40. doi: 10.1007/s000180050160.
Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials.
Qian H, Ye Z, Pi L, Ao J.
Mater Today Bio. 2022 Sep 6;16:100419. doi: 10.1016/j.mtbio.2022.100419. eCollection 2022 Dec.
